Charles Schwab Investment Management Inc Tango Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 379,477 shares of TNGX stock, worth $3.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
379,477
Previous 369,066
2.82%
Holding current value
$3.26 Million
Previous $3.65 Million
17.52%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TNGX
# of Institutions
127Shares Held
88.8MCall Options Held
2KPut Options Held
1.6K-
Trv Gp Iv, LLC Boston, MA19.2MShares$165 Million73.88% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$114 Million3.02% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$70.3 Million3.39% of portfolio
-
Nextech Invest Ag5.53MShares$47.5 Million8.22% of portfolio
-
Southpoint Capital Advisors LP New York, NY5.28MShares$45.3 Million0.95% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $756M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...